Kenner company purchases Imperial building

Goman, Kit
February 1994
New Orleans CityBusiness (1994 to 2008);2/7/94, Vol. 14 Issue 31, p10
Reports on the company Langley Roch's purchase of the Imperial office building on Causeway Boulevard in Metairie, Louisiana. Total office space of the building.


Related Articles

  • PCX President Resigns After OptiMark Launch. O'Reilly, Michael L. // Traders Magazine;Mar99, Vol. 12 Issue 149, p22 

    Reports on the resignation of Warren Langley as president and chief operating officer of the Pacific Exchange (PCX) after the launch of the OptiMark Trading System. Reason for hiring Langley as president of PCX; Contributions of Langley to PCX; Plans of Langley.

  • LaRoche Gains Complete Control of ChlorAlp. MILMO, SEAN // Chemical Market Reporter;03/29/99, Vol. 255 Issue 13, p6 

    Reports the plan of LaRoche Industries to purchase a share in ChlorAlp company. Details on the plan; Information on the company; Output of the chloralkali operation of the company.

  • Novartis Buys a Stake in Roche. Hume, Claudia // Chemical Week;5/16/2001, Vol. 163 Issue 20, p7 

    Reports on equity stake purchased by Novartis AG in Roche. Reason for the acquisition; Details on the company to be formed if the merger of the two companies will pursue; Challenges faced in the possible merger.

  • Tools Firm Illumina Considers Roche's Unsolicited $5.7B Bid. Shaffer, Catherine // BioWorld Today;1/26/2012, Vol. 23 Issue 17, p1 

    The article reports on the consideration of Illumina Inc.'s board of directors of an unsolicited offer made by Roche AG. The offer includes the purchase of the company's outstanding shares for 5.7 billion dollars. In a statement issued by Severin Schwan, chief executive officer (CEO) of Roche,...

  • Roche buys Boehringer Mannheim push into diagnostics market.  // Chemical Market Reporter;06/02/97, Vol. 251 Issue 22, p5 

    Reports on Switzerland-based Roche Holding Ltd.'s plan to acquire Corange Ltd. Terms of the purchase agreement; Company background.

  • Roche acquires BioImagene in $100M debt-free deal.  // Medical Device Daily;8/24/2010, Vol. 14 Issue 164, p1 

    The article reports on the acquisition of Biolmagene by Roche's subsidiary Ventana Medical Systems. According to Roche, the deal's purchase price is around 100 million U.S. dollars on a debt-free basis. Daniel O'Day, chief operating officer (COO) at Roche Diagnostics, said that the move will...

  • Roche releases green report. Cozier, Muriel // European Chemical News;4/5/2004, Vol. 80 Issue 2094, p21 

    Deals with the commitment to sustainable development highlighted by Roche at its annual report. Comments from Franz Humer, Roche chairman and chief executive officer; Progress in the company's environmental protection activities.

  • Genentech grapples with direct offer. Huggett, Brady // Nature Biotechnology;Mar2009, Vol. 27 Issue 3, p212 

    The article discusses a cash tender offer provided by F. Hoffman-La Roche to shareholders of the company Genentech. While Roche wishes to purchase shares at $86.50 apiece, Genentech is urging its shareholders to wait for a higher offer. Roche filings with the U.S. Securities and Exchange...

  • Syratech Corp. adds Imperial Crystal to mix.  // Gifts & Decorative Accessories;June97, Vol. 98 Issue 6, p8 

    Reports on Syratech Corporation of Massachusetts, purchasing of New Jersey Imperial Crystal company. How will Syratech market Imperial Crystal products; Acquisition of other companies; Distribution and marketing of consumer products.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics